Download Full Text (176 KB)
Neuroleptic malignant syndrome; Atypical NMS; Aripiprazole induced NMS; Afebrile NMS
Internal Medicine | Nervous System Diseases | Psychiatry
Neuroleptic Malignant Syndrome (NMS) is a rare, but potentially life threatening condition associated with dopamine blockade, particularly first-generation antipsychotics. The complex pathophysiology of NMS remains somewhat unclear and debatable as the symptoms are not fully explained by dopamine blockade alone.1 D2 dopamine receptor antagonism remains responsible for most cases of NMS, however a few cases have been reported in which little to no D2 blockade activity was present.1
This poster is about an atypical presentation of NMS.
Forte, Rudy MD; Kamath, Shiwani MD; Angelo, Debra MD; and Frunzi, Johnathan MD, "An Atypical Presentation of Neuroleptic Malignant Syndrome" (2020). West Florida Division Virtual Research Day. 1.